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Abstract
The opportunistic pathogen Pseudomonas aeruginosa produces colorful redox-active metabolites 
called phenazines, which underpin biofilm development, virulence and clinical outcomes. Though 
phenazines exist in many forms, the best studied is pyocyanin. Here, we describe pyocyanin 
demethylase (PodA), a hitherto uncharacterized protein that oxidizes the pyocyanin methyl group 
to formaldehyde and reduces the pyrazine ring via an unusual tautomerizing demethylation 
reaction. Treatment with PodA disrupts P. aeruginosa biofilm formation similarly to DNase, 
suggesting interference with the pyocyanin-dependent release of extracellular DNA into the 
matrix. PodA-dependent pyocyanin demethylation also restricts established biofilm aggregate 
populations experiencing anoxic conditions. Together, these results show that modulating 
extracellular redox-active metabolites can influence the fitness of biofilms.
Bacteria from phylogenetically diverse taxa secrete colorful redox-active metabolites, such 
as the well-studied phenazines produced by multiple species, including Pseudomonas 
aeruginosa (1, 2) (Fig. 1A,B). Phenazines can be toxic to other cells but also benefit their 
producers by facilitating extracellular electron transfer and survival in anoxic environments 
(3–6). These latter functions support the growth of antibiotic-resistant biofilms, and P. 
aeruginosa mutants that cannot make phenazines are defective in biofilm development (5). 
Accordingly, we reasoned that selectively manipulating phenazines might present a means to 
control biofilms. One way to influence extracellular metabolites is through active 
modification or degradation by other organisms (7–9). Recently, we described a group of 
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mycobacteria that enzymatically degrade phenazines and identified genes that catalyze 
distinct steps in degradation (9). Here, we focus on the structure and function of a previously 
uncharacterized protein from Mycobacterium fortuitum encoded by MFORT_14352 (NCBI 
Accession number: EJZ13467) that catalyzes pyocyanin (PYO) degradation (9).
To characterize its activity, we purified a heterologously expressed, truncated version of this 
protein (lacking a predicted N-terminal, membrane-spanning helix (10)), hereafter referred 
to as PodA30–162 (PYO demethylase), from Escherichia coli (Fig. 1C). PodA30–162 converts 
PYO to 1-hydroxyphenazine (1–OH-PHZ) and formaldehyde (Fig. 1D,E), indicating that it 
functions as a demethylase. Generally, enzyme-catalyzed N-demethylations proceed by 
oxidation of the methyl group to formaldehyde with electron transfer to a bound cofactor or 
iron-sulfur cluster (11, 12). Surprisingly, we found that PodA30–162 generates 1-OH-PHZ in 
the absence of either flavin or 2-oxoglutarate, which are required for most known N-
demethylases (Fig. S1). Additionally, PodA30–162 functions under anoxic conditions 
suggesting a mechanism distinct from the oxygen-dependent Rieske-iron type demethylases 
(13). Kinetic analysis suggests that PodA is a high affinity PYO demethylase (Km < 1 µM 
and kcat = 1.20 ± 0.07 s−1) that operates over a wide regime of pH (<4.9 – 8.7) and salt 
concentrations (0 – 400 mM) (Fig. S2) with specificity for N-methylated phenazines (Fig 
S3). Under anoxic conditions, PodA30–162 catalyzes the formation of a reduced phenazine, 
suggesting that its substrate serves as the electron acceptor (Fig. 1F,G). This mechanism has 
not previously been observed for demethylases (11, 12). We propose the following reaction 
for PodA, wherein oxidized PYO (PYOox) is converted to reduced 1-OH-PHZ (1–OH-
PHZred) (Fig. 1A,B):
C13H10N2O (PYOox) + H2O → C12H10N2O (1-OH-PHZred) + CH2O
To test this model and better understand how PodA30–162 reduces its substrate, we solved the 
X-ray crystal structure at 1.8 Å resolution (Table S1) by molecular replacement using a 
search model generated by Robetta (14–16) (Fig. S4). PodA30–162 crystalized as a trimer in 
the asymmetric unit (Fig. 2A). Crystal formation occurred only in the presence of 1-OH-
PHZ, which was visible in a putative solvent-exposed active site (Fig. 2B,C). We found no 
evidence of a bound cofactor or metals in the electron density of the active site (Fig. S5) 
further supporting the hypothesis that PodA catalyzes a novel demethylation reaction. 
Within the active site, there are several charged and polar residues (D68, D72, H121, E154, 
and Y156) and a nearby disulfide that are candidate catalytic residues (17); additionally, 1-
OH-PHZ appears to bind via a π-π stacking interaction with F70 (Fig. 2B).
Based on the active site structure, we propose a mechanism relying on the presence of H121 
functioning as an acid and D72, E154 and Y156 collectively functioning as a base (Fig. 2D). 
PYO binds in the phenol tautomeric form (Fig. 1A). Deprotonation of the methyl group 
results in iminium ion formation and concomitant reduction of the pyrazine ring, with the 
second nitrogen atom protonated by H121. H121 is then reprotonated by PYO’s hydroxyl 
group (pKa of His ~6 versus PYO ~5). The unfavorable interaction between the negatively 
charged phenolate ion and D68 drives product release. We hypothesize that PodA catalyzes 
the tautomerization of PYO to an iminium ion that is susceptible to hydrolysis outside of the 
enzyme: the structure indicates that the active site cannot accommodate both the substrate 
and a water molecule (Fig. 2B–E) (11). D72 and E154 remain protonated in this scenario, 
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acidifying the active site, perhaps to ensure that PYO is in the hydroxylated form in 
subsequent reaction cycles (Fig. 1A). This scheme highlights the significance of the 
hydroxyl group of PYO to recharge PodA for subsequent reaction cycles and to drive 
product release. An alternative substrate, methoxyphenazine methosulfate (methoxy-PMS), 
which lacks the hydroxyl group, displays an initial burst of activity followed by a slower 
steady state (Fig. 3A), which is consistent with our model.
To probe the proposed mechanism, we performed mutagenesis for each of the putative 
catalytic residues. H121A, E154A, D68A, and D72N mutants all formed a trimer (Fig. 
3B,C) but had <10% wild type activity, consistent with the postulated catalytic mechanism 
(Fig. 3D). Y156F formed a trimer but retained ~25% wild type activity, consistent with this 
residue facilitating proton transfer to D72 and E154 but not being essential. A possible 
alternative mechanism could utilize the disulfide in the active site forming a covalent adduct 
with the phenazine, in analogy to some flavoproteins (18). However, our mutagenesis results 
indicate that the disulfide bond near the active site is not essential for catalytic activity 
although it may be important for structural stability (Fig. 3B–D) (Fig. S6).
Because PodA requires only water and substrate for activity (Figs. 2D,E, S1, and S2), we 
hypothesized that it could degrade PYO during active production by P. aeruginosa (Fig. S7). 
PodA30–162 addition to P. aeruginosa planktonic culture results in the conversion of PYO to 
1-OH-PHZ in both rich and minimal medium (Fig. S8). Encouraged by these findings, we 
assessed the impact of PodA on biofilm formation. Extracellular DNA (eDNA) comprises 
>50% of the P. aeruginosa biofilm matrix (19), and recently PYO was shown to drive eDNA 
release (20, 21) which is important early in biofilm development (19). We hypothesized that 
PodA30–162 might inhibit P. aeruginosa biofilms in part by attenuating DNA release, thereby 
removing an important matrix component and changing biofilm architecture. Because PYO 
does not completely block DNA release (20, 21), it is also possible that downstream PYO-
DNA interactions may be important. We checked whether PodA30–162 could access PYO in 
the presence of DNA, as PYO is a known DNA intercalator (22); PodA30–162 catalyzed PYO 
demethylation in this context (Fig S8). We grew P. aeruginosa biofilms for 5 hours, staining 
them with DAPI to image biofilm structure. HPLC analysis of supernatants confirmed the 
conversion of PYO to 1-OH-PHZ by PodA30–162 in these cultures (Fig. 4A). Overall biofilm 
formation, as assayed by surface coverage (22), was reduced by PodA30–162 but not by the 
inactive PodA control (Fig. 4B–D), consistent with a role for PYO in early biofilm 
development. As previously shown, treatment with DNase independently inhibited biofilms 
(22). Interestingly, DNase or PodA30–162 treatment inhibited biofilms to the same extent, 
and dual treatment did not have an additive effect (Fig. 4D).
In addition to impacting early stages in biofilm development, phenazines can expand the 
habitable zone within established biofilms (5, 23). As P. aeruginosa biofilms mature, cells in 
deeper layers of the biofilm begin to experience oxygen limitation and redox stress (4, 23); 
these cells are believed to be slow growing and are highly resistant to antibiotics (24). 
Phenazines facilitate anoxic survival and alleviate redox stress (3, 25). Because PYO reacts 
with oxygen more efficiently than 1-OH-PHZ (26), we hypothesized that PodA activity 
might decrease anoxic fitness by disrupting PYO dependent electron shuttling to oxygen. To 
capture key features of in vivo biofilm aggregates (27, 28), cells were grown suspended in 
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agar blocks at 37 °C for 22 hours to establish an oxygen gradient before a 5 hour treatment 
with PodA30–162 (Fig. 4E,F). Owing to constraints imposed by the incubator, we were 
unable to measure oxygen gradients directly, so we used a previously validated model to 
estimate the oxic-anoxic transition zone (29). Modeling our aggregate population indicated 
that anoxia occurs ~300 µm below the surface as a result of microbial consumption (Fig. 
4G), consistent with what is known about oxygen diffusion into in vivo biofilms (29). We 
observed a decrease in detectable aggregates at depths 300–400 µm below the agar surface; 
additionally, cultures treated with PodA30–162 had a sharper decline in detectable aggregates 
below this depth (Fig. 4H). There was no significant difference in aggregate numbers above 
the predicted oxic-anoxic transition zone. How PYO demethylation restricts the aggregate 
population is unknown.
In conclusion, the discovery of a PYO demethylase that simultaneously catalyzes substrate 
reduction shows that redox-active pigments can participate in their own enzyme-catalyzed 
modification. Though PodA is the first member of a new class of tautomerizing 
demethylases that utilizes an oxidized substrate as the electron acceptor, this reaction is 
reminiscent of reduced flavin acting as the electron donor in its own destruction in vitamin 
B12 biosynthesis (30). It seems likely that the processing of other redox-active pigments and 
cofactors may operate by a similar mechanism where the redox activity of the substrate 
enables catalysis. That PodA can inhibit P. aeruginosa at different stages of biofilm 
development raises the possibility that selective degradation of extracellular electron shuttles 
may facilitate treatment of intractable infections.
Supplementary Material
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Figure 1. Biochemical analysis of the PodA reaction
PodA catalyzes the demethylation of PYO (A) to reduced 1-OH-PHZ (B). (C) PodA30–162 
purifies as a trimer by gel filtration chromatography (45.6 kDa). Inset is a denaturing gel 
demonstrating the size of monomeric PodA30–162. Incubations of PodA30–162 with PYO 
show the conversion of the starting material (D) to 1-OH-PHZ and formaldehyde (E). Data 
are average measurements from six reactions and error bars represent one standard deviation 
around the mean. Formaldehyde is derivatized to facilitate detection; the derivatization 
competes with other compounds in the mixture so stoichiometric production was not 
observed. (F) PodA30–162 is active under anoxic conditions, and the PYO containing 
reaction mixture fluoresces under UV illumination. This fluorescent product has an emission 
spectrum (250 nm excitation) consistent with a reduced phenazine (G). While both reduced 
PYO and 1-OH-PHZ have similar emission maxima (50 µM phenazine), the magnitude of 
the peak is consistent with the generation of reduced 1-OH-PHZ by PodA30–162.
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Figure 2. 1.8 Å crystal structure of PodA30–162
(A) View of the PodA30–162 trimer with 1-OH-PHZ bound. The PodA active site (B) is 
solvent exposed (C) and contains charged and polar residues. There is a nearby disulfide 
~3.5 Å from 1-OH-PHZ. (D) A proposed reaction mechanism based on the residues present 
in the active site. The model predicts that D72, E154 and Y156 are necessary for methyl 
deprotonation. H121 protonates the unmethylated N atom of the pyrazine ring, and D68 
reprotonates H121. Formation of the negatively charged phenolate ion promotes product 
release due to an unfavorable electrostatic interaction (red dashed circle). D72 and E154 
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remain protonated, acidifying the active site to assist in formation of hydroxylated PYO 
(Fig. 1A) in the next catalytic cycle. (E) Hydrolysis of the product is spontaneous and occurs 
after release from the active site.
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Figure 3. Molecular analysis of the PodA reaction mechanism
(A) An alternative substrate — methoxy-PMS, inset — is demethylated by PodA30–162, but 
the reaction rate slows significantly after an initial burst, highlighting the importance of the 
hydroxyl group of PYO for catalysis and/or driving product release after deprotonation. Data 
are averages from triplicate measurements and error bars represent one standard deviation 
from the mean. (B) Residues in the PodA active site (Fig. 2B) were mutated and the 
resulting proteins purified; H121A, D68A, E154A, D72N, Y156F and the C88A, C102A (C 
to A) double mutant all purify as a trimer by gel filtration chromatography. (C) Mutant 
proteins were pure as assayed by reducing SDS-PAGE. (D) Activity of mutant proteins 
shows that the disulfide bond is not essential for activity. Y156F has ~25% wild type 
activity, and all other residues appear essential for catalysis.
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Figure 4. PodA30–162 inhibits biofilm formation and anoxic fitness of P. aeruginosa
(A) Phenazines were measured by HPLC in biofilm supernatants after 5 hours of growth. 
PCA, phenazine-1-carboxylic acid. (B) P. aeruginosa forms a robust biofilm in the presence 
of inactivated PodA30–162 after 5 hours. (C) In the presence of PodA30–162, biofilm surface 
coverage was decreased. Surface coverage was 43.5 percent compared with 82.7 percent in 
the absence of PodA30–162 in the representative images shown. Scale Bars = 20 µm. (D) 
Surface coverage was lower in the presence of PodA30–162 (p < 10−6 vs. PodA-inactive, two-
tailed Student’s t-test). DNase addition decreased surface coverage (p < 10−3 vs. PodA-
inactive), but DNase and PodA30−162 combined did not have an additive effect (p > 0.05), 
consistent with an interaction between PYO and eDNA in supporting biofilms (22). Data are 
averages of 12 replicates taken from independent cultures. Error bars represent one standard 
deviation around the mean. ∆phz, PA14 mutant incapable of making phenazines. (E) Top 
down and (F) side views of P. aeruginosa grown embedded in 0.5% agar blocks for 27 hours. 
Scale bars = 200 µm. Oxygen depletion occurs at lower depths as a result of biological 
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consumption outpacing diffusion from the surface, resulting in decreased biomass. (G) 
Oxygen diffusion model predicting the shape of the oxycline in agar blocks. Cell densities 
were estimated at 108.7 cells mL−1 based on aggregate number and volume. Modeling this 
concentration and 2-fold higher and lower densities suggests that oxygen depletion occurs 
~300 µm ± 100 µm below the agar surface. Dashed red line indicates the approximate oxic-
anoxic interface. (H) Biofilm aggregates detected at 10 µm increments below the agar 
surface. At depths near the oxic/anoxic interface (dashed red line), total biomass begins to 
decline. In assays treated for the last 5 hours with PodA30−162, there is an apparent biomass 
defect specifically at anoxic depths compared to untreated and inactive PodA treated 
controls, consistent with the importance of PYO for anoxic survival in P. aeruginosa. Data 
are averages of six independent experiments and error bars represent one standard deviation 
around the mean. Open symbols, p < 0.01, two-tailed Student’s t-test.
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